Wearable Cardioverter Defibrillator Market: By Medical Condition; By End User & By Region - Forecast 2016-2022

  • ID: 4033439
  • Report
  • 166 pages
  • IndustryARC
1 of 3
Wearable cardioverter defibrillator (WCD) is a medical device worn by cardiac patients who are at risk for sudden cardiac arrest (SCA). A wearable cardioverter defibrillator allows their physician time to assess their long-term arrhythmic risk and make appropriate plans for preventing sudden cardiac arrest resulting in a fatality. Globally, an increasing number of people with cardiac diseases and technological advancement in cardiology are expected to remain the key growth drivers for the wearable cardioverter defibrillator during the period of study.

Geographically, North America dominated the wearable cardioverter defibrillator market driven by world class healthcare infrastructure with a technologically advanced practice, higher spending and presence of key industry players in the region. North America was followed by Europe and Asia-Pacific as second and third largest market for the wearable cardioverter defibrillator market. Asia Pacific is projected to have the fastest growth, owing to a rapidly developing medical infrastructure, increasing spending on healthcare and growing medical tourism in developing nations such as China and India in this region.

This report identifies the wearable cardioverter defibrillator market size for the years 2014-2016, and forecast of the same till the year 2022. It also highlights the market drivers, restraints, growth indicators, challenges, and other key aspects with respect to the wearable cardioverter defibrillator market.

This report segments the wearable cardioverter defibrillator market on the basis of medical condition, end-user and regional market as follows:
Wearable cardioverter defibrillator market research report is classified on the basis of medical condition. Some of the major medical conditions covered in this report are as follows: Peripartum Cardiomyopathy, Congenital Heart Disease, Inherited Arrhythmias

Wearable cardioverter defibrillator market research report is classified on the basis of end-user. Some of the major end-users covered in this report are as follows: Hospitals, Home Care, Cardiology Clinics
This report has been further segmented into major regions, which includes detailed analysis of each region such as: North America, Europe, Asia-Pacific (APAC), and Rest of the World (RoW) covering all the major country level markets in each of the region
This report identifies all the major companies operating in the wearable cardioverter defibrillator market. Some of the major companies’ profiles in detail are as follows:

ZOLL Medical Corporation (A Subsidiary of Asahi Kasei Corporation)
Access Cardio Systems
BIOTRONIC SE & Co. KG
Boston Scientific Corporation
Cardiac Science Corporation
Please Note: The report is to be delivered in 1-2 working days after an order is placed.
READ MORE
Note: Product cover images may vary from those shown
2 of 3
1. Wearable cardioverter defibrillator Market – Overview

2. Executive Summary

3. Wearable cardioverter defibrillator Market Landscape
3.1. Market Share Analysis
3.2. Comparative Analysis
3.3. Product Benchmarking
3.4. End User Profiling
3.5. Top 5 Financials Analysis

4. Wearable cardioverter defibrillator Market– Forces
4.1. Drivers
4.1.1. Technological advancement in cardiology
4.1.2. Increasing population with cardiac diseases
4.2. Restraints
4.3. Opportunities
4.4. Challenges
4.5. Porter’s Five Forces Analysis
4.5.1. Bargaining Power of Suppliers
4.5.2. Bargaining Power of Buyers
4.5.3. Threat of New Entrants
4.5.4. Threat of Substitutes
4.5.5. Degree of Competition

5. Wearable cardioverter defibrillator Market– Strategic Analysis
5.1. Value Chain Analysis
5.2. Pricing Analysis
5.3. Opportunities Analysis
5.4. Product/Market Life Cycle Analysis
5.5. Suppliers and Distributors

6. Wearable cardioverter defibrillator Market, By Medical Condition
6.1. Peripartum Cardiomyopathy
6.2. Congenital Heart Disease
6.3. Inherited Arrhythmias

7. Wearable cardioverter defibrillator Market, By End-User
7.1. Hospitals
7.2. Home Care
7.3. Cardiology Clinics

8. Wearable cardioverter defibrillator Market, By Geography
8.1. Europe
8.1.1. Germany
8.1.2. France
8.1.3. Italy
8.1.4. Spain
8.1.5. Russia
8.1.6. U.K.
8.1.7. Rest of Europe
8.2. Asia Pacific
8.2.1. China
8.2.2. India
8.2.3. Japan
8.2.4. South Korea
8.2.5. Rest of Asia-Pacific
8.3. North America
8.3.1. U.S.
8.3.2. Canada
8.3.3. Mexico
8.4. Rest of the World (RoW)
8.4.1. Brazil
8.4.2. Rest of RoW

9. Wearable cardioverter defibrillator Market – Entropy
9.1. Expansion
9.2. Technological Developments
9.3. Merger & Acquisitions, and Joint Ventures
9.4. Supply- Contract

10. Company Profiles (Overview, Financials, SWOT Analysis, Developments, Product Portfolio)
10.1. ZOLL Medical Corporation (A Subsidiary of Asahi Kasei Corporation)
10.2. Access Cardio Systems
10.3. BIOTRONIC SE & Co. KG
10.4. Boston Scientific Corporation
10.5. Cardiac Science Corporation
10.6. Defibtech LLC
10.7. GE Healthcare
10.8. HeartSine Technologies
10.9. Medtronic Inc
10.10. Nihon Kohden corporation
10.11. Phillips Healthcare
*More than 40 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"

11. Appendix
11.1. Abbreviations
11.2. Sources
11.3. Research Methodology
11.4. Bibliography
11.5. Compilation of Expert Insights
11.6. Disclaimer
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll